BeiGene Gets CHMP Nod for TEVIMBRA® in Advanced Gastric and Esophageal Cancers
BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company, announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has…